NIH-funded research R01 grant

Identifying genetic factors that cause weight gain from antipsychotic medications

Official title: Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic risk

Funded at Washington University · NIH-11003663 · Data updated 2026-11-12

This study is looking at how your genes might affect weight gain from antipsychotic medications, which can lead to health issues like diabetes and heart disease, and it's for both kids and adults to help find better ways to manage these risks.

More Weight Gain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startFebruary 12, 2021
Project endDecember 31, 2025
Funding year2025
Award (this year)$606,127
NIH project number5R01MH122686-05
Project IDNIH-11003663 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals of all ages who are prescribed antipsychotic medications and are experiencing weight gain or related health issues.

Less likely to help

Patients who are not taking antipsychotic medications or those without concerns related to weight gain or cardiometabolic risks may not benefit from this research.

What this research studies

This research investigates how certain genetic factors contribute to weight gain caused by antipsychotic medications, which can lead to serious health risks like diabetes and heart disease. By using advanced genetic analysis and existing patient data, the study aims to pinpoint specific genes that influence weight gain and metabolic health across different age groups. The research focuses on understanding these effects in both children and adults, addressing the unique ways that age impacts weight gain from these medications. Ultimately, the goal is to develop personalized treatment strategies that could mitigate these risks for patients.

Why it matters

Potential benefit: If successful, this research could lead to personalized treatment options that reduce weight gain and associated health risks for patients taking antipsychotic medications.

How similar studies have gone: Previous research has shown success in identifying genetic factors related to weight gain and metabolic risks, but this study aims to apply a novel approach that has not been extensively tested.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Nicol, Ginger E — Washington University
  • Study coordinator: Nicol, Ginger E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.